Drug Type siRNA |
Synonyms BW 00112, BW00112 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dyslipidemias | Phase 2 | US | 21 Jun 2024 | |
Hypertriglyceridemia | Phase 2 | CN | 17 Apr 2024 | |
Metabolic Diseases | Phase 1 | AU | 21 Feb 2023 | |
Nutrition Disorders | Phase 1 | AU | 21 Feb 2023 |